Youth ADHD Peer-facilitated Support Group: Age 16-24

ADHD Surge in Transition Years

Attention-deficit/hyperactivity disorder (ADHD) diagnoses and stimulant prescriptions have risen sharply in Canada, particularly since the COVID-19 pandemic. In Ontario, new annual stimulant prescriptions climbed 157% from 275 per 100,000 people in 2015 to 708 in 2023, with annual growth jumping to 29% after 2020 compared with 7% beforehand. The most pronounced increases occurred among adults, especially women: females aged 18-24 saw a 369% rise, and those 25-44 a 421% increase, flipping previous patterns where males dominated prescriptions.

This shift reflects multiple factors. Heightened online content about adult ADHD, the proliferation of private virtual assessment clinics during lockdowns, and reduced barriers to diagnosis all contributed. While greater recognition helps those previously overlooked—especially females, whose symptoms often present differently and go undetected longer—it also raises questions about potential overdiagnosis or misattribution of milder issues.

For youth aged 16-24, the stakes are concrete. This transitional period involves leaving high school, entering post-secondary education or work, managing independence, and navigating relationships—all areas where unmanaged ADHD impairs executive function, time management, and emotional regulation. Untreated or poorly supported ADHD in this group correlates with higher dropout rates, job instability, anxiety, depression, and risky behaviours. With roughly 5-7% of Canadian children affected and persistence into adulthood for most, the cohort now entering or in young adulthood numbers in the hundreds of thousands.

Formal healthcare struggles to keep pace. Public system wait times for assessments can stretch months to years in many provinces, pushing people toward private options that may vary in rigour. Medication supply issues have periodically disrupted treatment continuity. In this environment, peer-facilitated groups provide low-barrier, lived-experience-based support that complements clinical care, addressing isolation and building practical coping skills without long waits or high costs.

Tensions exist between improved access and risks of inappropriate prescribing, as well as between medical models focused on medication and psychosocial approaches emphasizing peer connection. The rise also highlights gender dynamics: as more young women receive diagnoses, support must adapt to their often internalized symptoms and societal pressures.